Evgen Pharma Share Discussion Threads

[dutch123] 18/5/2021 18:57

Although we are seeing tenths of a penny fluctuation, this can leap by the 10pences..and more, mm's trying to make a market.

[amaretto1] 18/5/2021 17:26

Well I've bought a few more today ....i must be wrong in my head !!We will see

[markth126] 18/5/2021 17:19

Well the 75k at 7.2 was a buy for sure as it me rounding up my holding

[moneymunch] 18/5/2021 16:59

All smoke and mirrors, the 7.20p trades are buys imho and the 2m and 1.8m look like duplicates from yesterday, both listed on Lse , delayed historical publication from yesterday and non protected portfolio etc......news fast approaching....Gla ;-))))

[peanut100] 18/5/2021 16:51

Defo seller but good volume yesterday and today should clear them soon before the small bounce back to 8p awaiting any news.

[moneymunch] 18/5/2021 16:43

Yep....good news coming imho....Gla ;-)

[1xtrader] 18/5/2021 16:23

I don't think it's the seller, it's the market maker dropping the price and loading up on cheap shares from the weak who he will then sell for profit when the news breaks

[fozzie] 18/5/2021 16:23

Remind me why I took loads in the recent placing, awful price reaction since, yellow card has been issued.

[lovewinshatelosses] 18/5/2021 16:16

On target - exactly the example I was thinking of too; similarly for 4D afterwards and a few others I have seen since then also.
How nice it would be for history to repeat itself here for those of us who are brave/stupid enough to be holding on for said results :)
Mentally ready for the worst though and not advising anyone to follow suit, etc.

[on target] 18/5/2021 16:09

I console myself with the fact that SNG also had at least two large sellers prior to its positive trial results. If you read the SNG thread a few days before their RNS it's all about sellers, FCAP on the offer etc. - all the same stuff we're seeing.

[lovewinshatelosses] 18/5/2021 16:07

Well, I cannot say that I am enjoying this share price action so close to results, but if I did not already have a silly amount of shares here, then I would probably buy a few more after a deep breath nonetheless!
Hopefully it is not a case of bad news leaking, but I am sitting tight come what may now, just in case these chunky sells are not linked to inside knowledge. GLA

[pugugly] 18/5/2021 15:01

Now seems to be in free fall - 7.2p bid - Buyers seem to be able to get stock at about 7.3 - Anyone like to call the bottom?

[1xtrader] 18/5/2021 14:37

Marketmaker manipulation

[muddy_40] 18/5/2021 07:52

PDT

Good find. Sulforaphane seems to be able to fix any medical condition. A bit of a super drug.

[pdt] 18/5/2021 07:44

Muddy - that is interesting and there is a connection between NETs/COVID/Sulforaphane.

The role of Neutrophil Extracellular Traps in Covid-19: Only an hypothesis or a potential new field of research?



"If it is true that the production of NETs occurs in conjunction with ROS increase, it is rational to study signal pathways involved in the response to oxidative stress, such as the pathway regulated by the Nuclear erytroid-related factor 2 (Nrf2) Nrf2/antioxidant related elements (ARE), the main transcription factor involved in antioxidant defence [23]. Possible therapeutic implications with Nrf2 activators (such as Resveratrol and Sulforaphane) [24,25] may then be considered"

[muddy_40] 18/5/2021 05:10

No mention of the Star Covid trial, Maybe she was dedicated to the Stopcovid.

A University of Dundee postgrad is in the running to be crowned PhD Student of the Year following a dramatic 12 months that have seen her work on potential treatments for Covid-19 as well as being named as one of the best young scientists in her field.

Holly’s work on NETs was a key factor in setting up STOP-COVID, a major UK-wide clinical trial of a drug it is hoped may help to prevent the worst ravages of the disease by blocking NETs. She is co-lead of the lab team examining how the drug, Brensocatib, affects the immune system in patients with Covid-19.